1. Breviscapine alleviates NASH by inhibiting TGF‐β‐activated kinase 1‐dependent signaling. Issue 1 (19th December 2021) Authors: Lan, Tian; Jiang, Shuo; Zhang, Jing; Weng, Qiqing; Yu, Yang; Li, Haonan; Tian, Song; Ding, Xin; Hu, Sha; Yang, Yiqi; Wang, Weixuan; Wang, Lexun; Luo, Duosheng; Xiao, Xue; Piao, Shenghua; Zhu, Qing; Rong, Xianglu; Guo, Jiao Journal: Hepatology Issue: Volume 76:Issue 1(2022) Page Start: 155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cordycepin Ameliorates Nonalcoholic Steatohepatitis by Activation of the AMP‐Activated Protein Kinase Signaling Pathway. Issue 2 (26th August 2021) Authors: Lan, Tian; Yu, Yang; Zhang, Jing; Li, Haonan; Weng, Qiqing; Jiang, Shuo; Tian, Song; Xu, Tonghao; Hu, Sha; Yang, Guizhi; Zhang, Yan; Wang, Weixuan; Wang, Lexun; Zhu, Qing; Rong, Xianglu; Guo, Jiao Journal: Hepatology Issue: Volume 74:Issue 2(2021) Page Start: 686 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Kaempferol prevents acetaminophen-induced liver injury by suppressing hepatocyte ferroptosis via Nrf2 pathway activation. Issue 4 (26th January 2023) Authors: Li, Huiyi; Weng, Qiqing; Gong, Shuai; Zhang, Weixian; Wang, Jiaqi; Huang, Yuqiao; Li, Yuanjun; Guo, Jiao; Lan, Tian Journal: Food & function Issue: Volume 14:Issue 4(2023) Page Start: 1884 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗